Amlodipine and Hyphaema - a phase IV clinical study of FDA data

Summary:

Hyphaema is reported as a side effect among people who take Amlodipine (amlodipine besylate), especially for people who are male, 60+ old, also take Lisinopril, and have Intraocular pressure increased.

The phase IV clinical study analyzes which people have Hyphaema when taking Amlodipine. It is created by eHealthMe based on reports of 346,875 people who have side effects when taking Amlodipine from the FDA, and is updated regularly.

What is Amlodipine?

Amlodipine has active ingredients of amlodipine besylate. It is often used in high blood pressure. eHealthMe is studying from 354,833 Amlodipine users. Check the latest studies of Amlodipine.

What is Hyphaema?

Hyphaema (collection of blood inside the front part of the eye) is found to be associated with 85 drugs and 125 conditions by eHealthMe. Check the latest studies of Hyphaema.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

346,875 people reported to have side effects when taking Amlodipine.
Among them, 20 people (0.01%) have Hyphaema.

Among these 20 people:

What is the gender of people who have Hyphaema when taking Amlodipine? *

female: 12.5 %
male: 87.5 %

What is the age of people who have Hyphaema when taking Amlodipine? *

What are other drugs people take besides Amlodipine? *

What are other side effects people have besides Hyphaema? *

Fall: 6 people, 30.00%
Oxygen Saturation Decreased: 4 people, 20.00%
Dizziness: 4 people, 20.00%
Limb Injury: 4 people, 20.00%
Vision Blurred: 4 people, 20.00%
Joint Pain: 4 people, 20.00%
Blood Pressure Diastolic Abnormal: 4 people, 20.00%
Upper Respiratory Tract Infection: 4 people, 20.00%
Vitreous Haemorrhage (intraocular (inside the eye) bleeding): 4 people, 20.00%
Body Temperature Decreased: 4 people, 20.00%

What are the existing conditions these people have? *

Type 2 Diabetes: 4 people, 20.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 20.00%
Intraocular Pressure Increased: 4 people, 20.00%
Joint Pain: 3 people, 15.00%
Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 3 people, 15.00%
Stress And Anxiety: 3 people, 15.00%
Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 15.00%
Rashes (redness): 3 people, 15.00%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 10.00%
Hiv Infection: 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Amlodipine and have Hyphaema?

- Check whether Hyphaema is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Amlodipine:

Amlodipine (354,833 reports)

Hyphaema treatments and more:

Hyphaema (684 reports)

Browse all side effects of Amlodipine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyphaema:

Hyphaema (85 drugs)

Browse all the conditions that are associated with Hyphaema:

Hyphaema (125 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate (the active ingredients of Amlodipine) and Amlodipine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.